CL2018000228A1 - Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos. - Google Patents

Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos.

Info

Publication number
CL2018000228A1
CL2018000228A1 CL2018000228A CL2018000228A CL2018000228A1 CL 2018000228 A1 CL2018000228 A1 CL 2018000228A1 CL 2018000228 A CL2018000228 A CL 2018000228A CL 2018000228 A CL2018000228 A CL 2018000228A CL 2018000228 A1 CL2018000228 A1 CL 2018000228A1
Authority
CL
Chile
Prior art keywords
drug resistant
resistant bacteria
new effective
aminoglycoside antibiotic
effective aminoglycoside
Prior art date
Application number
CL2018000228A
Other languages
English (en)
Inventor
Yoshiaki Takahashi
Eijiro Umemura
Takashi Ida
Masayuki Igarashi
Original Assignee
Meiji Seika Pharma Co Ltd
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Pharma Co Ltd, Microbial Chem Res Found filed Critical Meiji Seika Pharma Co Ltd
Publication of CL2018000228A1 publication Critical patent/CL2018000228A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPUESTOS DERIVADOS DE AMINOGLUCÓSIDO; COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE; Y SU USO EN LA PREVENCIÓN O TRATAMIENTO DE ENFERMEDADES INFECCIOSAS. 
CL2018000228A 2015-07-30 2018-01-26 Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos. CL2018000228A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015151250 2015-07-30

Publications (1)

Publication Number Publication Date
CL2018000228A1 true CL2018000228A1 (es) 2018-08-24

Family

ID=57884581

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018000228A CL2018000228A1 (es) 2015-07-30 2018-01-26 Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos.

Country Status (23)

Country Link
US (2) US10617704B2 (es)
EP (2) EP3330275A4 (es)
JP (1) JP6938376B2 (es)
KR (1) KR102590696B1 (es)
CN (1) CN108026133B (es)
AR (1) AR105547A1 (es)
AU (1) AU2016300993B2 (es)
CA (1) CA2993425A1 (es)
CL (1) CL2018000228A1 (es)
CO (1) CO2018001237A2 (es)
HK (1) HK1254239A1 (es)
IL (1) IL257151B (es)
MX (1) MX2018001022A (es)
MY (1) MY186959A (es)
NZ (1) NZ740037A (es)
PH (1) PH12018500202A1 (es)
RU (1) RU2751634C2 (es)
SA (1) SA518390825B1 (es)
SG (2) SG11201800510WA (es)
TW (1) TWI699372B (es)
UA (1) UA123629C2 (es)
WO (1) WO2017018528A1 (es)
ZA (1) ZA201801312B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2751634C2 (ru) * 2015-07-30 2021-07-15 Майкробиал Кемистри Рисерч Фаундейшн Новый эффективный аминогликозидный антибиотик против бактерий с множественной лекарственной резистентностью
JP2020055749A (ja) * 2017-01-27 2020-04-09 公益財団法人微生物化学研究会 多剤耐性菌に有効な新規アミノグリコシド抗生物質
JP7313631B2 (ja) * 2017-05-01 2023-07-25 ウェイン ステート ユニバーシティー アプラマイシン誘導体
JP2021138615A (ja) * 2018-05-31 2021-09-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 多剤耐性菌に有効なアミノグリコシド抗生物質の製造方法
CN116462721B (zh) * 2023-04-18 2024-02-02 江南大学 抗菌性氨基糖苷衍生物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4424344A (en) 1980-09-22 1984-01-03 Eli Lilly And Company 2-N-Acylated and 2-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides and process
US4424345A (en) 1980-09-22 1984-01-03 Eli Lilly And Company 1-N-Acylated and 1-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides and process
US4468513A (en) 1980-09-22 1984-08-28 Eli Lilly And Company 2'-N-Acylated and 2'-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides
JPS5782399A (en) * 1980-09-22 1982-05-22 Lilly Co Eli 2-deoxystreptamine aminoglycoside derivative and manufacture
JPS5782398A (en) 1980-09-22 1982-05-22 Lilly Co Eli 2-deoxystreptamine aminoglycoside derivative
JPS5772998A (en) 1980-10-24 1982-05-07 Shionogi & Co Ltd Novel appamycin derivative
JPS5772999A (en) 1980-10-24 1982-05-07 Shionogi & Co Ltd Novel 5-deoxyapramycin
US4385585A (en) * 1981-10-27 1983-05-31 Copco, Inc. Teakettle having whistle cap
US4379917A (en) * 1981-12-24 1983-04-12 Eli Lilly And Company 6"-(Substituted)-apramycin antibiotic derivatives and intermediates and starting materials therefor
US4360665A (en) * 1981-12-24 1982-11-23 Eli Lilly And Company 4"-N-(Substituted)-apramycin antibiotic derivatives and intermediates therefor
US4458065A (en) * 1983-02-17 1984-07-03 Eli Lilly And Company 7-N-(Substituted-apramycin antibiotic derivatives and intermediates therefor
AU2007235408A1 (en) 2006-04-07 2007-10-18 E.I. Du Pont De Nemours And Company Processes for chemical synthesis of lipochitooligosaccharides
RU2458931C2 (ru) * 2006-06-02 2012-08-20 Мейдзи Сейка Фарма Ко., Лтд. Новые аминогликозидные антибиотики
AU2008326297B2 (en) 2007-11-21 2012-11-08 Cipla USA, Inc. Antibacterial aminoglycoside analogs
TWI472521B (zh) 2008-07-17 2015-02-11 Lexicon Pharmaceuticals Inc （２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法
EP2616079B1 (en) * 2010-09-13 2015-10-14 University of Zürich Treatment of bacterial infectious diseases
WO2013191550A1 (en) * 2012-06-20 2013-12-27 Rijksuniversiteit Groningen Regioselective diazotation of aminoglycosides
RU2491921C1 (ru) 2012-07-11 2013-09-10 Общество с ограниченной ответственностью "Опытно-технологическая фирма "Этрис" Способ лечения мастита у коров в сухостойный период
RU2751634C2 (ru) * 2015-07-30 2021-07-15 Майкробиал Кемистри Рисерч Фаундейшн Новый эффективный аминогликозидный антибиотик против бактерий с множественной лекарственной резистентностью

Also Published As

Publication number Publication date
JPWO2017018528A1 (ja) 2018-05-17
CN108026133B (zh) 2021-05-07
RU2751634C2 (ru) 2021-07-15
TW201718616A (zh) 2017-06-01
TWI699372B (zh) 2020-07-21
RU2018107150A (ru) 2019-08-29
IL257151B (en) 2021-01-31
UA123629C2 (uk) 2021-05-05
MY186959A (en) 2021-08-26
US20200155582A1 (en) 2020-05-21
SG11201800510WA (en) 2018-02-27
CN108026133A (zh) 2018-05-11
SG10201913231RA (en) 2020-03-30
KR20180043791A (ko) 2018-04-30
MX2018001022A (es) 2018-05-17
AR105547A1 (es) 2017-10-11
SA518390825B1 (ar) 2021-06-01
ZA201801312B (en) 2019-07-31
KR102590696B1 (ko) 2023-10-18
AU2016300993A1 (en) 2018-02-15
US11135234B2 (en) 2021-10-05
NZ740037A (en) 2024-08-30
IL257151A (en) 2018-03-29
JP6938376B2 (ja) 2021-09-22
RU2018107150A3 (es) 2019-12-27
US20180214470A1 (en) 2018-08-02
EP3330275A1 (en) 2018-06-06
WO2017018528A1 (ja) 2017-02-02
PH12018500202B1 (en) 2018-07-30
US10617704B2 (en) 2020-04-14
HK1254239A1 (zh) 2019-07-12
EP3498723A1 (en) 2019-06-19
EP3330275A4 (en) 2018-12-05
BR112018001849A2 (pt) 2018-09-18
CA2993425A1 (en) 2017-02-02
PH12018500202A1 (en) 2018-07-30
CO2018001237A2 (es) 2018-05-10
AU2016300993B2 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
CL2014001956A1 (es) Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas.
CL2018000228A1 (es) Nuevo antibiótico efectivo de aminoglucósido para bacterias resistentes a múltiples fármacos.
CL2017001798A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas.
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CL2018003135A1 (es) Derivados aromáticos de sulfonamida.
CL2015002891A1 (es) Deaza-purinonas macrocíclicas para el tratamiento de infecciones virales.
CL2017002482A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas
UY37036A (es) Compuestos inhibidores de la quinasa de unión a tank
CL2016000493A1 (es) Inhibidores de polimerasa hcv.
CL2016002877A1 (es) Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos.
CL2015002855A1 (es) Derivados de oxopiridina sustituida.
CL2015001864A1 (es) Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih.
CL2015001916A1 (es) Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral.
BR112016020199A2 (pt) Composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
CL2013002898A1 (es) Compuestos derivados de benceno sustituido con arilo o heteroarilo; composicion farmaceutica que los comprende y uso en el tratamiento del cancer.
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
CL2016000568A1 (es) Compuestos derivados de 2h-indazol-2-il-n-hidroxi-2-metilsulfonil-2-metil-butanamida sustituidos o sus sales; sus composiciones farmacéuticas que los contiene y su uso para la prevención y/o tratamiento de infecciones bacterianas gram-negativas.
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
CL2017002803A1 (es) Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas